NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/11/2026
Back to search
Official data from USPTO
PROTA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROTA THERAPEUTICS
ST13
US500000079221443Class
5, 44
Filing
79221443
Registration
5771963
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/12/2026
Trademark type
Word
Nice classes
5, 44
Filing date
10/10/2017
Registration date
06/11/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2026
Last transaction
06/12/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
LAM, HAI-LY HUYNH
Current location
Historical data usage
Holders and representatives
Holders
Prota Therapeutics Pty Ltd
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Active specific immunotherapy agents for the treatment of allergic and intolerance disorders; antigens for the prevention and treatment of allergic and intolerance disorders; probiotic bacterial formulations for medical use; probiotic bacterial preparations for medical use; pharmaceutical preparations for oral useoral immunotherapy preparations for prevention and treatment of allergic and intolerance conditions; medical preparations for modifying allergic and intolerance conditionsconditions affecting the gastrointestinal tractskinairways and/or lungs; pharmaceutical preparations for the treatment of food allergies or intolerancesother allergic and intolerance conditionsof the gastrointestinal tractskinairways and/or lungsall of the foregoing for oral administration only
Class 44
Treatment of allergies; medical services; medical treatment and advisory services; medical testing and analysis services for the diagnosis of allergic and intolerance disorders; medical diagnostic servicesfor the diagnosis of allergic and intolerance disorders; provision of pharmaceutical informationpharmaceutical information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
38 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/11/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2026
ES71
TEAS SECTION 71 RECEIVED
12/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/11/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/24/2019
FIMP
FINAL DISPOSITION PROCESSED
09/24/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/10/2019
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/07/2019
APET
ASSIGNED TO PETITION STAFF
05/06/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/24/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/24/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/11/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/01/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
10/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/02/2018
PUBO
PUBLISHED FOR OPPOSITION
10/02/2018
GPNX
NOTIFICATION PROCESSED BY IB
09/29/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/12/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/12/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/12/2018
ALIE
ASSIGNED TO LIE
08/27/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/27/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/27/2018
RFNT
REFUSAL PROCESSED BY IB
02/16/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/29/2018
RFRR
REFUSAL PROCESSED BY MPU
01/29/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/23/2018
CNRT
NON-FINAL ACTION WRITTEN
01/22/2018
DOCK
ASSIGNED TO EXAMINER
01/18/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/23/2017
Continuous trademark protection
Get notified about every new filing that threatens PROTA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.